Sherwood Jennifer B, Sagalowsky Arthur I
Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX 75390-9110, USA.
Urol Oncol. 2006 Jul-Aug;24(4):356-61. doi: 10.1016/j.urolonc.2005.11.027.
To illustrate the problem of urethral recurrence of transitional cell carcinoma (TCC) after radical cystectomy, and define surveillance and treatment algorithms.
There are 6 unique cases of urethral tumor recurrence presented, and current relevant literature is reviewed. Three risk groups are defined based on the likelihood of urethral recurrence. Surveillance and treatment options are delineated.
Although the incidence of recurrent tumor in the urethra is low, the prevalence is increasing because of improvements in bladder cancer survival and the fact that the urethra is retained more often for orthotopic urinary diversion. Patients can be categorized as low, intermediate, and high risk based on the pathologic finding of degree of prostatic involvement by the initial tumor.
Based on limited available literature, it appears that surveillance strategies range from observation alone to more invasive monitoring that includes urethral wash cytology and urethroscopy. Treatment options include local resection, intraurethral agents, and complete urethrectomy. A surveillance algorithm based on risk for recurrence and a treatment algorithm based on histopathologic risk factors of the recurrent tumor are proposed. This problem will assume increasing importance in the future.
阐述根治性膀胱切除术后移行细胞癌(TCC)尿道复发的问题,并确定监测及治疗方案。
呈现6例独特的尿道肿瘤复发病例,并对当前相关文献进行综述。根据尿道复发的可能性定义了三个风险组。划定了监测及治疗选项。
尽管尿道复发肿瘤的发生率较低,但由于膀胱癌生存率的提高以及原位尿流改道时尿道保留更为常见,其患病率正在上升。根据初始肿瘤累及前列腺程度的病理结果,患者可分为低、中、高风险组。
基于有限的现有文献,监测策略似乎从单纯观察到更具侵入性的监测,包括尿道冲洗细胞学检查和尿道镜检查。治疗选项包括局部切除、尿道内用药和全尿道切除术。提出了基于复发风险的监测方案以及基于复发性肿瘤组织病理学风险因素的治疗方案。这个问题在未来将变得越来越重要。